Related Experiment Video
Updated: Aug 9, 2025
05:23
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
6.2K
Rlip Protein: A Potential Target for COVID-19
Jonathan Kopel1, Sharda P Singh1, Ashly Hindle1
1Department of Internal Medicine, Division of Hematology & Oncology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Journal of Community Hospital Internal Medicine Perspectives
|February 23, 2023
Summary
Researchers propose RLIP76 (RALBP1) as a novel target for treating SARS-CoV-2 infections. This protein, involved in cellular processes and previously linked to viral illnesses, could offer a new therapeutic strategy against COVID-19.
Area of Science:
- Virology
- Cell Biology
- Drug Discovery
Background:
- The COVID-19 pandemic necessitates novel therapeutic targets beyond existing treatments.
- Clathrin-dependent endocytosis (CDE) is a primary mechanism for viral entry into host cells.
- Current COVID-19 treatments show limited efficacy in reducing mortality.
Purpose of the Study:
- To investigate RLIP76 (RALBP1) as a potential therapeutic target for SARS-CoV-2 infections.
- To explore the role of clathrin-dependent endocytosis inhibition in combating viral entry.
Main Methods:
- Review of existing literature on viral pathogenesis and cellular mechanisms.
- Analysis of RLIP76's known functions in cellular transport and stress response.
- Exploration of potential CDE inhibition strategies.
Main Results:
- RLIP76 (RALBP1) plays a role in cellular transport and is regulated by G-proteins.
- Previous studies link RLIP76 to the pathogenesis of various viral illnesses.
- No prior studies have investigated CDE inhibition for COVID-19 treatment.
Conclusions:
- RLIP76 (RALBP1) is proposed as a novel therapeutic target for SARS-CoV-2.
- Inhibiting clathrin-dependent endocytosis may represent a new strategy against COVID-19.
- Further research is warranted to validate RLIP76 as a COVID-19 therapeutic target.
Related Concept Videos
02:50Conjugated Proteins
18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
02:28Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
01:31Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K